PortalPublikationenTransaxillary transcatheter ACURATE neo aortic valve implant...

Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study

Standard

Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study. / Amat-Santos, Ignacio J; Santos-Martínez, Sandra; Conradi, Lenard; Taramasso, Maurizio; Poli, Arnaldo; Romaguera, Rafael; Pan, Manuel; Bagur, Rodrigo; Del Valle, Raquel; Nombela-Franco, Luis; Bhadra, Oliver D; Aparisi, Álvaro; Redondo, Alfredo; Gutiérrez, Hipólito; Gómez, Itziar; Roman, J Alberto San.

in: CATHETER CARDIO INTE, Jahrgang 98, Nr. 2, 01.08.2021, S. E291-E298.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Amat-Santos, IJ, Santos-Martínez, S, Conradi, L, Taramasso, M, Poli, A, Romaguera, R, Pan, M, Bagur, R, Del Valle, R, Nombela-Franco, L, Bhadra, OD, Aparisi, Á, Redondo, A, Gutiérrez, H, Gómez, I & Roman, JAS 2021, 'Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study', CATHETER CARDIO INTE, Jg. 98, Nr. 2, S. E291-E298. https://doi.org/10.1002/ccd.29423

APA

Amat-Santos, I. J., Santos-Martínez, S., Conradi, L., Taramasso, M., Poli, A., Romaguera, R., Pan, M., Bagur, R., Del Valle, R., Nombela-Franco, L., Bhadra, O. D., Aparisi, Á., Redondo, A., Gutiérrez, H., Gómez, I., & Roman, J. A. S. (2021). Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study. CATHETER CARDIO INTE, 98(2), E291-E298. https://doi.org/10.1002/ccd.29423

Vancouver

Amat-Santos IJ, Santos-Martínez S, Conradi L, Taramasso M, Poli A, Romaguera R et al. Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study. CATHETER CARDIO INTE. 2021 Aug 1;98(2):E291-E298. https://doi.org/10.1002/ccd.29423

Bibtex

@article{ac0fae23a42c4af88bc7c68dac41156d,
title = "Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study",
abstract = "BACKGROUND: Transcatheter aortic valve replacement (TAVR) via transaxillary (TAx) approach with ACURATE neo valve is an off-label procedure. Our aim was to gather information on ACURATE neo cases implanted via TAx approach and report major outcomes.METHODS AND RESULTS: The TRANSAX Study (NCT04274751) retrospectively gathered patients from nine centres in Europe and North America treated with ACURATE neo valve through TAx approach up to May/2019. Follow up was pre-specified at 1-year and was obtained for all patients. A total of 75 patients (79 ± 10 years; 32% women) were included. Left axillary (72%) and conscious sedation (95.2%) were the most common setting. Risk scores were higher when right axillary artery and surgical cut-down were selected. Severe complications including valve embolization, coronary obstruction, annulus rupture, and procedural mortality did not occur. Cardiac tamponade occurred in two cases (2.7%) with one requiring conversion to open surgery (1.3%). Bail-out stenting and surgical vascular repair were required in 7 (9.3%) and 3 (4%) cases, respectively. The need for new permanent pacemaker was 8%. Procedural success (96%), in-hospital (2.7%), and 1-year mortality (8%) were comparable in all settings. Only one case (1.3%) complicated with cerebrovascular event and one (1.3%) presented moderate aortic regurgitation before discharge.CONCLUSIONS: TAx TAVR procedures with the ACURATE neo valve were presented high success rate and low in-hospital and 1-year mortality.",
keywords = "Aortic Valve/diagnostic imaging, Aortic Valve Stenosis/diagnostic imaging, Female, Heart Valve Prosthesis, Humans, Male, Prosthesis Design, Retrospective Studies, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome",
author = "Amat-Santos, {Ignacio J} and Sandra Santos-Mart{\'i}nez and Lenard Conradi and Maurizio Taramasso and Arnaldo Poli and Rafael Romaguera and Manuel Pan and Rodrigo Bagur and {Del Valle}, Raquel and Luis Nombela-Franco and Bhadra, {Oliver D} and {\'A}lvaro Aparisi and Alfredo Redondo and Hip{\'o}lito Guti{\'e}rrez and Itziar G{\'o}mez and Roman, {J Alberto San}",
note = "{\textcopyright} 2020 Wiley Periodicals LLC.",
year = "2021",
month = aug,
day = "1",
doi = "10.1002/ccd.29423",
language = "English",
volume = "98",
pages = "E291--E298",
journal = "CATHETER CARDIO INTE",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study

AU - Amat-Santos, Ignacio J

AU - Santos-Martínez, Sandra

AU - Conradi, Lenard

AU - Taramasso, Maurizio

AU - Poli, Arnaldo

AU - Romaguera, Rafael

AU - Pan, Manuel

AU - Bagur, Rodrigo

AU - Del Valle, Raquel

AU - Nombela-Franco, Luis

AU - Bhadra, Oliver D

AU - Aparisi, Álvaro

AU - Redondo, Alfredo

AU - Gutiérrez, Hipólito

AU - Gómez, Itziar

AU - Roman, J Alberto San

N1 - © 2020 Wiley Periodicals LLC.

PY - 2021/8/1

Y1 - 2021/8/1

N2 - BACKGROUND: Transcatheter aortic valve replacement (TAVR) via transaxillary (TAx) approach with ACURATE neo valve is an off-label procedure. Our aim was to gather information on ACURATE neo cases implanted via TAx approach and report major outcomes.METHODS AND RESULTS: The TRANSAX Study (NCT04274751) retrospectively gathered patients from nine centres in Europe and North America treated with ACURATE neo valve through TAx approach up to May/2019. Follow up was pre-specified at 1-year and was obtained for all patients. A total of 75 patients (79 ± 10 years; 32% women) were included. Left axillary (72%) and conscious sedation (95.2%) were the most common setting. Risk scores were higher when right axillary artery and surgical cut-down were selected. Severe complications including valve embolization, coronary obstruction, annulus rupture, and procedural mortality did not occur. Cardiac tamponade occurred in two cases (2.7%) with one requiring conversion to open surgery (1.3%). Bail-out stenting and surgical vascular repair were required in 7 (9.3%) and 3 (4%) cases, respectively. The need for new permanent pacemaker was 8%. Procedural success (96%), in-hospital (2.7%), and 1-year mortality (8%) were comparable in all settings. Only one case (1.3%) complicated with cerebrovascular event and one (1.3%) presented moderate aortic regurgitation before discharge.CONCLUSIONS: TAx TAVR procedures with the ACURATE neo valve were presented high success rate and low in-hospital and 1-year mortality.

AB - BACKGROUND: Transcatheter aortic valve replacement (TAVR) via transaxillary (TAx) approach with ACURATE neo valve is an off-label procedure. Our aim was to gather information on ACURATE neo cases implanted via TAx approach and report major outcomes.METHODS AND RESULTS: The TRANSAX Study (NCT04274751) retrospectively gathered patients from nine centres in Europe and North America treated with ACURATE neo valve through TAx approach up to May/2019. Follow up was pre-specified at 1-year and was obtained for all patients. A total of 75 patients (79 ± 10 years; 32% women) were included. Left axillary (72%) and conscious sedation (95.2%) were the most common setting. Risk scores were higher when right axillary artery and surgical cut-down were selected. Severe complications including valve embolization, coronary obstruction, annulus rupture, and procedural mortality did not occur. Cardiac tamponade occurred in two cases (2.7%) with one requiring conversion to open surgery (1.3%). Bail-out stenting and surgical vascular repair were required in 7 (9.3%) and 3 (4%) cases, respectively. The need for new permanent pacemaker was 8%. Procedural success (96%), in-hospital (2.7%), and 1-year mortality (8%) were comparable in all settings. Only one case (1.3%) complicated with cerebrovascular event and one (1.3%) presented moderate aortic regurgitation before discharge.CONCLUSIONS: TAx TAVR procedures with the ACURATE neo valve were presented high success rate and low in-hospital and 1-year mortality.

KW - Aortic Valve/diagnostic imaging

KW - Aortic Valve Stenosis/diagnostic imaging

KW - Female

KW - Heart Valve Prosthesis

KW - Humans

KW - Male

KW - Prosthesis Design

KW - Retrospective Studies

KW - Transcatheter Aortic Valve Replacement/adverse effects

KW - Treatment Outcome

U2 - 10.1002/ccd.29423

DO - 10.1002/ccd.29423

M3 - SCORING: Journal article

C2 - 33315296

VL - 98

SP - E291-E298

JO - CATHETER CARDIO INTE

JF - CATHETER CARDIO INTE

SN - 1522-1946

IS - 2

ER -